2013
DOI: 10.1007/s11418-013-0754-3
|View full text |Cite
|
Sign up to set email alerts
|

The involvement of magnoflorine in the sedative and anxiolytic effects of Sinomeni Caulis et Rhizoma in mice

Abstract: The present study seeks to evaluate the sedative and anxiolytic effects of the 70% ethanol extract of Sinomeni Caulis et Rhizoma (SR). The extract was orally administered to mice at dosages of 25, 50, 100, 200 or 400 mg/kg. The mice were then subjected to an array of behavioral tests to assess the sedative (open-field, rota-rod, and thiopental sodium-induced sleeping test) and anxiolytic (elevated plus maze test) effects of the substance. SR (100, 200 mg/kg) significantly reduced locomotor activity, decreased … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
12
0
1

Year Published

2014
2014
2024
2024

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 38 publications
(13 citation statements)
references
References 28 publications
0
12
0
1
Order By: Relevance
“…P. Fernandez et al, 2008;Flores et al, 2006;Fortes et al, 2013;Fraser et al, 2010;Frassetto et al, 2010;Galeotti et al, 2013;Girish et al, 2013;Gomes et al, 2010;Ma Eva Gonzalez-Trujano et al, 2006;Maria Eva Gonzalez-Trujano et al, 2015;González-Pardo et al, 2006;Griebel et al, 1998;1999a;1999b;Guilloux et al, 2013;Gupta et al, 2014;Han et al, 2009;Harada et al, 2006;Hasenohrl et al, 1996;Hazim et al, 2014;Huerta-Reyes et al, 2013;Hui et al, 2002;Ishaq, 2014;N. S. Jain et al, 2005;Jastrzebska-Wiesek et al, 2014;Jászberényi et al, 2009;Jessa et al, 1996;Jones et al, 1994;Kalouda and Pitsikas, 2015;Karakas et al, 2011;Karim et al, 2011;Kebebew and Shibeshi, 2013;Klodzinska et al, 2004a;2004b;Kong et al, 2006;Kumar and Bhat, 2014;Kurhe et al, 2014;Kuribara et al, 2000;la Pena et al, 2013;LaBuda and Fuchs, 2001;Langen et al, 2005;Leggio et al,...…”
Section: Summary Measuresunclassified
“…P. Fernandez et al, 2008;Flores et al, 2006;Fortes et al, 2013;Fraser et al, 2010;Frassetto et al, 2010;Galeotti et al, 2013;Girish et al, 2013;Gomes et al, 2010;Ma Eva Gonzalez-Trujano et al, 2006;Maria Eva Gonzalez-Trujano et al, 2015;González-Pardo et al, 2006;Griebel et al, 1998;1999a;1999b;Guilloux et al, 2013;Gupta et al, 2014;Han et al, 2009;Harada et al, 2006;Hasenohrl et al, 1996;Hazim et al, 2014;Huerta-Reyes et al, 2013;Hui et al, 2002;Ishaq, 2014;N. S. Jain et al, 2005;Jastrzebska-Wiesek et al, 2014;Jászberényi et al, 2009;Jessa et al, 1996;Jones et al, 1994;Kalouda and Pitsikas, 2015;Karakas et al, 2011;Karim et al, 2011;Kebebew and Shibeshi, 2013;Klodzinska et al, 2004a;2004b;Kong et al, 2006;Kumar and Bhat, 2014;Kurhe et al, 2014;Kuribara et al, 2000;la Pena et al, 2013;LaBuda and Fuchs, 2001;Langen et al, 2005;Leggio et al,...…”
Section: Summary Measuresunclassified
“…Magnoflorine is an important kind of aporphine alkaloid that exists in many herbs, including Berberidaceae, Euphorbiaceae (Dwumabadu et al, 1980), Magnoliaceae (Mohamed et al, 2010) and Ranunculaceae (Chen et al, 2009). Modern pharmacological studies have shown that magnoflorine has a variety of pharmacological and biological effects, including antifungal activities (Chen et al, 2009), antioxidation (Hung et al, 2007a(Hung et al, , 2007bHisatomi et al, 2000), anti-inflammation (Sharma et al, 2012;Küpeli et al, 2002), sedative, anxiolytic (de la Peña et al, 2013) and antidiabetic activities (Patel and Mishra, 2011, 2012a, 2012bChen et al, 2012). Recently, considerable attention has been focused on its antidiabetic effects with the purpose of developing magnoflorine as a potential agent.…”
Section: Introductionmentioning
confidence: 99%
“…The most representative of aporphine alkaloids is apomorphine (Hattori and Nomoto, 2014;Bogucki, 2013), which is a well established treatment for the management of sudden, unexpected and refractory levodopa-induced 'off' states in fluctuating Parkinson's disease. Studies have also shown magnoflorine to have sedative and anxiolytic effects (de la Peña et al, 2013). This suggests that magnoflorine has pharmacological activities acting on the brain and playing a considerable role that cannot be ignored in Coptidis Rhizoma.…”
Section: Introductionmentioning
confidence: 99%
“…Both N-methylcytisine [110] and anagyrine [534] have been shown to be teratogenic, however. The aporphine alkaloid magnoflorine, on the other hand, has shown sedative and anxiolytic effects [535] and may be responsible for the anti-convulsive and sedative uses of C. thalictroides in Cherokee traditional medicine.…”
Section: Caulophyllum Thalictroides (L) Michxmentioning
confidence: 99%